Showing results (1101-1110 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|January 27, 2017
NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolutionMeriem Messaoudene, Giulia Fregni, David Enot, et al.
Oncoimmunology|January 27, 2017
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomasJana K Sonner, Katrin Deumelandt, Martina Ott, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
Oncoimmunology|January 27, 2017
Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemiaCarolina Cubillos-Zapata, Jose Avendaño-Ortiz, Raúl Córdoba, et al.
Oncoimmunology|January 27, 2017
The tumor microenvironment disarms CD8+ T lymphocyte function via a miR-26a-EZH2 axisHaixia Long, Tong Xiang, Jing Luo, et al.
Oncoimmunology|January 27, 2017
Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myelomaAlejandra Leivas, Antonio Perez-Martinez, María Jesús Blanchard, et al.
Oncoimmunology|January 27, 2017
Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized studyXiang-Yu Zhao, Xiao-Su Zhao, Yu-Tong Wang, et al.
Oncoimmunology|January 27, 2017
BTLA identifies dysfunctional PD-1-expressing CD4+ T cells in human hepatocellular carcinomaQiyi Zhao, Zhan-Lian Huang, Min He, et al.
Oncoimmunology|January 27, 2017
PD-1/PD-L1 inhibitors in multiple myeloma: The present and the futureT Jelinek, R Hajek
Oncoimmunology|May 7, 2014
Why should we need the gut microbiota to respond to cancer therapies?Sophie Viaud, Romain Daillère, Takahiro Yamazaki, et al.
Pageof 379